Akouos, Inc. (AKUS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

645 SUMMER STREET, SUITE 200 BOSTON, MA 02210

Akouos is a precision genetic medicine company dedicated to developing gene therapies with the potential to restore, improve, and preserve high-acuity physiologic hearing for individuals living with disabling hearing loss worldwide. Leveraging its precision genetic medicine platform that incorporates a proprietary adeno-associated viral (AAV) vector library and a novel delivery approach, Akouos is focused on developing precision therapies for forms of sensorineural hearing loss. Headquartered in Boston, Akouos was founded in 2016 by leaders in the fields of neurotology, genetics, inner ear drug delivery, and AAV gene therapy.

Data as of 2021-08-02 09:14:29 -0400
Market Cap374.464 Million Shares Outstanding34.449 Million Avg 30-day Volume82.92 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.16 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.67588 52-week High/Low30.67 / 10.72 Next Earnings Date2021-08-12 Price to Cash FLow (P/CF) -26.8316
Data provided by IEX Cloud
View SEC Filings from AKUS instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 3 -33.33% 1 (0.06%) 2 (0.12%) -50.0%
Funds Holding: 74 61 21.31% 21 (1.23%) 20 (1.16%) 5.0%
13F shares: 33.1 Million 32.099 Million 3.12% 13.921 Million 14.609 Million -4.71%
% Ownership 96.2692 93.3595 3.12% 40.4893 42.4895 -4.71%
New Positions: 17 9 88.89% 3 1 200.0%
Increased Positions 25 27 -7.41% 2 8 -75.0%
Closed Positions 4 5 -20.0% 2 4 -50.0%
Reduced Positions 17 12 41.67% 9 6 50.0%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding AKUS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AKUS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PARMAR KUSH

  • Director
  • 10% Owner
16,000 2021-06-24 2

TZIANABOS ARTHUR

  • Director
16,000 2021-06-24 1

SMITH CHRISTOPHER M

  • Director
16,000 2021-06-24 1

RAMASASTRY SAIRA

  • Director
16,000 2021-06-24 1

SATO VICKI L

  • Director
16,000 2021-06-24 1

PRESTON HEATHER

  • Director
16,000 2021-06-24 1

MATHERS EDWARD T

  • Director
16,000 2021-06-24 1

ROBINSON GREGORY SCOTT CHIEF SCIENTIFIC OFFICER

  • Officer
0 2021-02-15 2

SIMONS EMMANUEL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2021-02-15 1

MCKENNA MICHAEL JOHN CHIEF MEDICAL OFFICER

  • Officer
0 2021-02-15 2

MINEGISHI SACHIYO CHIEF FINANCIAL OFFICER

  • Officer
0 2021-02-15 3

WELLMAN JENNIFER ANNE CHIEF OPERATING OFFICER

  • Officer
0 2021-02-15 3

5AM VENTURES V, L.P.

5AM PARTNERS V, LLC

5AM OPPORTUNITIES I, L.P.

5AM OPPORTUNITIES I (GP), LLC

ROCKLAGE SCOTT M

SCHWAB ANDREW J.

  • 10% Owner
4,135,784 2020-12-29 1

MARSHFIELD ADVISERS LLC

  • 10% Owner
No longer subject to file 2020-06-30 0

ECOR1 CAPITAL, LLC

  • 10% Owner
No longer subject to file 2020-06-30 0

SONSINI PETER W.

  • 10% Owner
4,294,207 2020-06-30 0

WALKER PAUL EDWARD

  • 10% Owner
4,294,207 2020-06-30 0

CORMORANT ASSET MANAGEMENT, LP

CHEN BIHUA

CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

CORMORANT PRIVATE HEALTHCARE FUND II, LP

  • Director
  • 10% Owner
  • FORMER 10% OWNER
No longer subject to file 2020-06-30 0

SANDELL SCOTT D

  • 10% Owner
4,294,207 2020-06-30 0

PIVOTAL BIOVENTURE PARTNERS FUND I, L.P.

PIVOTAL BIOVENTURE PARTNERS FUND I G.P., L.P.

  • 10% Owner
No longer subject to file 2020-06-30 0

MAKOWER JOSHUA

  • 10% Owner
4,294,207 2020-06-30 0

MAKHZOUMI MOHAMAD

  • 10% Owner
4,294,207 2020-06-30 0

FLORENCE ANTHONY A. JR.

  • 10% Owner
4,294,207 2020-06-30 0

CHANG CARMEN

  • 10% Owner
4,294,207 2020-06-30 0

PARTNERS INNOVATION FUND, LLC

  • 10% Owner
No longer subject to file 2020-06-30 0

BEHBAHANI ALI

  • 10% Owner
4,294,207 2020-06-30 0

PARTNERS INNOVATION FUND II, L.P.

  • 10% Owner
No longer subject to file 2020-06-30 0

BASKETT FOREST

  • 10% Owner
4,294,207 2020-06-30 0

NOVARTIS BIOVENTURES LTD

NOVARTIS AG

  • FORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2020-06-30 0

NEW ENTERPRISE ASSOCIATES 16, L.P.

NEA PARTNERS 16, L.P.

NEA 16 GP, LLC

  • 10% Owner
4,294,207 2020-06-30 0

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

RA CAPITAL NEXUS FUND, L.P.

KOLCHINSKY PETER

SHAH RAJEEV M.

  • 10% Owner
No longer subject to file 2020-06-30 0

SOFINNOVA VENTURE PARTNERS X, L.P.

SOFINNOVA MANAGEMENT X, L.L.C.

HEALY JAMES

KATABI MAHA

POWELL MICHAEL

  • 10% Owner
No longer subject to file 2020-06-30 0

MASSACHUSETTS EYE & EAR INFIRMARY

  • 10% Owner
118,635 2020-06-25 0

OZDEN RABIA GURSES CHIEF DEVELOPMENT OFFICER

  • Officer
0 2020-06-25 0

SOFINNOVA VENTURE PARTNERS X, L.P.

SOFINNOVA MANAGEMENT X, L.L.C.

HEALY JAMES

POWELL MICHAEL

  • 10% Owner
0 2020-06-25 0

LONZA HOUSTON, INC.

  • 10% Owner
118,635 2020-06-25 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SATO VICKI L - Director

2021-06-25 16:35:46 -0400 2021-06-24 A 16,000 a 16,000 direct

RAMASASTRY SAIRA - Director

2021-06-25 16:37:01 -0400 2021-06-24 A 16,000 a 16,000 direct

TZIANABOS ARTHUR - Director

2021-06-25 16:34:30 -0400 2021-06-24 A 16,000 a 16,000 direct

PRESTON HEATHER - Director

2021-06-25 16:37:45 -0400 2021-06-24 A 16,000 a 16,000 direct

SMITH CHRISTOPHER M - Director

2021-06-25 16:35:13 -0400 2021-06-24 A 16,000 a 16,000 direct

MATHERS EDWARD T - Director

2021-06-25 17:49:50 -0400 2021-06-24 A 16,000 a 16,000 direct

PARMAR KUSH - Director - > 10% Owner

2021-06-25 16:38:16 -0400 2021-06-24 A 16,000 a 16,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
AKOUOS INC AKUS 2021-08-05 22:15:04 UTC -0.4638 0.5438 150000
AKOUOS INC AKUS 2021-08-05 21:45:03 UTC -0.4638 0.5438 150000
AKOUOS INC AKUS 2021-08-05 21:15:03 UTC -0.4638 0.5438 150000
AKOUOS INC AKUS 2021-08-05 20:45:03 UTC -0.4638 0.5438 150000
AKOUOS INC AKUS 2021-08-05 20:15:04 UTC -0.4638 0.5438 150000
AKOUOS INC AKUS 2021-08-05 19:45:04 UTC -0.4638 0.5438 150000
AKOUOS INC AKUS 2021-08-05 19:15:03 UTC -0.4638 0.5438 150000
AKOUOS INC AKUS 2021-08-05 18:45:03 UTC -0.4638 0.5438 150000
AKOUOS INC AKUS 2021-08-05 18:15:03 UTC -0.4638 0.5438 150000
AKOUOS INC AKUS 2021-08-05 17:45:03 UTC -0.4638 0.5438 150000
AKOUOS INC AKUS 2021-08-05 17:15:03 UTC -0.4638 0.5438 150000
AKOUOS INC AKUS 2021-08-05 16:45:02 UTC -0.4756 0.5556 150000
AKOUOS INC AKUS 2021-08-05 16:15:03 UTC -0.4756 0.5556 150000
AKOUOS INC AKUS 2021-08-05 15:45:03 UTC -0.4756 0.5556 150000
AKOUOS INC AKUS 2021-08-05 15:15:02 UTC -0.4756 0.5556 150000
AKOUOS INC AKUS 2021-08-05 14:45:02 UTC -0.4851 0.5651 150000
AKOUOS INC AKUS 2021-08-05 14:15:04 UTC -0.4851 0.5651 150000
AKOUOS INC AKUS 2021-08-05 13:45:04 UTC -0.4851 0.5651 150000
AKOUOS INC AKUS 2021-08-05 13:15:03 UTC -0.4851 0.5651 150000
AKOUOS INC AKUS 2021-08-05 12:45:03 UTC -0.4851 0.5651 150000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund AKUS -1000.0 shares, $-13870.0 2021-03-31 N-PORT

Elevate your investments